According to official website, we know that as of June 25th, 2023, Hefei Tianmai has not closed down. Tianmai Biotechnology Co., Ltd. introduced recombinant human insulin enteric-coated capsules for the treatment of type 2 diabetes patients with poor efficacy of oral hypoglycemic drugs.